|
Beginning
Phased Rollout
Penn's Adverse Events Reporting System
We
are pleased to announce that on November 25, the Penn
Human Subjects Adverse Events Reporting (PennAEs)
component of the PennERA system was released to select
members of the University of Pennsylvania's academic
research community. PennAEs is a web-based software
solution that facilitates the tracking and collecting
of adverse events in clinical trials and the reporting
of serious adverse events involving human subjects
to the Institutional Review Boards of the University
of Pennsylvania.
The
system will be released in phases to facilitate orientation
and the support of new users of the system. Additional
members of the University community will be given
access throughout the fall. This phased rollout follows
a successful pilot release of the system that began
in September 2002. This is a first release and over
time, as hands-on use expands, there may be enhancements
to terminology and navigation features of the system.
This evolutionary approach to a new system and associated
processes will help ensure that PennAEs will facilitate
and enable improved tracking and information collection.
Faculty investigators and the members of their research
teams will be notified when PennAEs is available for
campus-wide use.
PennAEs
is one of the several components of the PennERA (Penn
Electronic Research Administration) project. This
multi-year project is designed to enhance the processes
that support research and grants administration at
the University.
If
you have any questions or would like more information
about the PennAEs component of the PennERA system,
or if you wish to register to use PennAEs, please
send an e-mail to pennaes@pobox.upenn.edu or
contact Chris Sandy at (215) 746-6266. For the most
up-to-date information on the PennERA project, visit
the web site at www.pennera.upenn.edu/.
--Robin
H. Beck, Vice President of Information Systems
and Computing
--Andrew
B. Rudczynski, Executive Director of Research
Services
and
Associate Vice President of Finance
--Joseph
R. Sherwin, Director of the Office of Regulatory
Affairs
|